
Andrew Darlington DO
Adult Congenital Heart Disease, Heart Failure & Transplantation
Advanced Heart Failure Cardiologist
Join to View Full Profile
1267 Highway 54 WSte 2200Fayetteville, GA 30214
Phone+1 404-605-2800
Fax+1 404-351-5983
Dr. Darlington is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Cardiovascular Disease, 2013 - 2014
University of Florida College of Medicine JacksonvilleFellowship, Cardiovascular Disease, 2010 - 2013
University of Florida College of Medicine JacksonvilleResidency, Internal Medicine, 2006 - 2009
Philadelphia College of Osteopathic MedicineClass of 2006
Certifications & Licensure
GA State License 2014 - 2028
FL State License 2009 - 2024
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Publications & Presentations
PubMed
- 114 citationsRapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart FailureJeffrey M. Testani, Jennifer S. Hanberg, Susan Cheng, Veena Rao, Chukwuma Onyebeke
Circulation. Heart Failure. 2016-01-01 - 14 citationsRole of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonistsFrancesco Franchi, Jafri Syed Hammad, Fabiana Rollini, Antonio Tello-Montoliu, Ronakkumar Patel
Journal of Thrombosis and Thrombolysis. 2015-07-01 - 148 citationsImpaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease.Dominick J. Angiolillo, Joseph A. Jakubowski, José Luis Ferreiro, Antonio Tello-Montoliu, Fabiana Rollini
Journal of the American College of Cardiology. 2014-09-09
Press Mentions
30 Signs of Deadly Health Conditions Hiding in Plain SightAugust 6th, 2019
Black Men and Heart Failure: How to Beat It This SummerAugust 2nd, 2019
Learn About Congestive Heart FailureFebruary 16th, 2016
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









